← Open Payments lookup

GABRIELLA PASZTOR: Open Payments

NPI 1659575231 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,352 in 108 payments from 10 companies in 2025. Trend: 2023 $2,357 · 2024 $1,727 · 2025 $2,352

Food & beverage: $2,240Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.30$754
Teva Pharmaceuticals USA, Inc.23$499
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$391
E.R. Squibb & Sons, L.L.C.14$293
Luye Pharma (USA) Ltd.13$165
Alkermes, Inc.5$124
Otsuka America Pharmaceutical, Inc.3$58
Janssen Pharmaceuticals, Inc2$30
Noven Therapeutics, LLC1$20
Vanda Pharmaceuticals Inc.1$17

Products named: INGREZZA, CAPLYTA, COBENFY, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE, UZEDY, ARISTADA, LYBALVI.

Industry payments across TX — which companies pay providers there.